Antibody Discovery Tools
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
1,542
NCT03984604
Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
Phase: Phase 2
Role: Collaborator
Start: Mar 21, 2019
Completion: Jun 17, 2020
NCT04708158
Novaferon for COVID-19 Treatment Trial (NCTT-005)
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 25, 2021
Completion: Apr 30, 2023
NCT04669015
Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19
Start: Jun 10, 2021
Completion: Aug 31, 2022
NCT05172037
Novaferon in Non-hospitalized Adult Patients With Mild COVID-19
Start: Oct 28, 2021
Completion: Jun 30, 2022
Loading map...